Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical
Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a strategic partnership with Olympus Corporation (Olympus), a global healthcare leader committed to making people’s lives healthier, safer, and more fulfilling through advanced medical technologies and solutions, aimed at harnessing external innovation to accelerate development and market entry for an endoluminal robotics platform initially targeting gastrointestinal (GI) treatments.
Revival Healthcare Capital is pleased to announce Todd M. Pope has joined Revival as a Partner
Todd M. Pope initially joined Revival as a Resident Operating Partner in February 2020 and after more than two years in this role, Revival is pleased to announce that Todd has been appointed as a Partner and a member of the Investment Committee. Todd will expand his leadership role within the firm’s investment team and will continue to serve as a Director on the Board of Distalmotion, a Revival portfolio company.
Revival Healthcare Capital Closes $500 Million Fund for Strategic Growth Investments
Private equity firm Revival Healthcare Capital (“Revival”) today announced the closing of RVLHC II with total capital commitments of $500 million. The fund will pursue strategic growth opportunities in which Revival will invest into a high potential target company where a corporate strategic partner will have a structural option or right to acquire the company in the future. This strategy leverages Revival’s capacity as operators and investors to build collaborative partnerships that increase corporate partners’ probability of return on future growth investments and provide accelerated paths for target companies to advance innovative medical device technologies into global markets.
